Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CLDN5PROTEIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Claudin 5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
No AI portrait yet
| Gene Symbol | CLDN5PROTEIN |
| Full Name | Claudin-5 Protein |
| Protein Family | Claudin family |
| Target Class | Structural Protein |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Mechanism of Action | Tight junction protein modulation - no established druggable mechanisms |
| Druggability | Undruggable (0.20) |
| Clinical Stage | Approved |
| Molecular Weight | 21.8 kDa |
| UniProt ID | O00511 |
| GeneCards | CLDN5PROTEIN |
| Human Protein Atlas | CLDN5PROTEIN |
| Two extracellular loops | The first extracellular loop determines charge selectivity |
| Cytoplasmic N- and C-termini | The C-terminus interacts with PDZ domain proteins including ZO-1, ZO-2, and ZO-3 |
| Associated Diseases | ALS, blood-brain barrier tight junction integrity, blood-retinal barrier integrity, Brain Edema, neurodegeneration, stroke |
| Known Drugs/Compounds | curcumin, resveratrol |
| Interactions | ABCB1, ABCD1, ABCD2, ABCG2, AMYLOID, AND |
| SciDEX Target | View Target Profile (5 clinical trials) |
| SciDEX Hypotheses | Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Plasma Claudin-5 Proteolytic Fragments Distinguish Vascular and Perivascular Cell Type Vulnerability: (+2 more) |
| KG Connections | 396 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CLDN5PROTEIN["CLDN5PROTEIN"]
neurodegeneration["neurodegeneration"]
CLDN5PROTEIN -->|"implicated_in"| neurodegeneration
style CLDN5PROTEIN fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CLDN5PROTEIN in their description or question text
No additional research found